These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 32384313)

  • 1. Fluoxetine-Induced "Rabbit Syndrome" in a Child With Juvenile Obsessive-Compulsive Disorder.
    Naguy A; Moodliar-Rensburg S; Elsori DH; Alamiri B
    Am J Ther; 2022 May-Jun 01; 29(3):e363-e364. PubMed ID: 32384313
    [No Abstract]   [Full Text] [Related]  

  • 2. Aripiprazole Treatment for Obsessive Compulsive Disorder in 2 Young Subjects Who Could Not Tolerate Selective Serotonin Reuptake Inhibitors (SSRIs).
    Coskun M; Karayagmurlu A
    J Clin Psychopharmacol; 2020; 40(3):310-312. PubMed ID: 32332471
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fluoxetine-induced tics in a child].
    Ceylan MF; Akca ÖF
    Turk Psikiyatri Derg; 2011; 22(1):61-2. PubMed ID: 21416809
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluoxetine-Induced Serum Sickness-Like Reaction in an Adolescent with Obsessive Compulsive Disorder and Diabetes.
    Bez Y; Coffey BJ
    J Child Adolesc Psychopharmacol; 2021 Nov; 31(9):646-649. PubMed ID: 34784233
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of fluoxetine in Austrian patients with obsessive-compulsive disorder.
    Zitterl W; Meszaros K; Hornik K; Twaroch T; Dossenbach M; Zitterl-Eglseer K; Zapotoczky HG
    Wien Klin Wochenschr; 1999 Jun; 111(11):439-42. PubMed ID: 10420495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aplastic anaemia during treatment with fluoxetine.
    Bosch X; Vera M
    Lancet; 1998 Apr; 351(9108):1031. PubMed ID: 9546514
    [No Abstract]   [Full Text] [Related]  

  • 7. Urinary Retention in an Adolescent Patient Caused by Fluoxetine Alone.
    Karadag M; Gokcen C; Bayar H; Aksoy I
    J Child Adolesc Psychopharmacol; 2015 Oct; 25(8):658. PubMed ID: 26485088
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluoxetine-Induced Skin Picking and Compulsive Behaviors in a Preschool Girl.
    Çoşkun F; Bilgiç A
    Clin Neuropharmacol; 2018; 41(5):192-193. PubMed ID: 30024442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine: therapeutic and undesirable effects.
    Cookson J; Duffett R
    Hosp Med; 1998 Aug; 59(8):622-6. PubMed ID: 9829055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sertraline and fluoxetine treatment of obsessive-compulsive disorder: results of a double-blind, 6-month treatment study.
    Bergeron R; Ravindran AV; Chaput Y; Goldner E; Swinson R; van Ameringen MA; Austin C; Hadrava V
    J Clin Psychopharmacol; 2002 Apr; 22(2):148-54. PubMed ID: 11910259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe and moderate hypertriglyceridemia secondary to citalopram and fluoxetine.
    Teitelbaum M
    Psychosomatics; 2000; 41(5):448-9. PubMed ID: 11015636
    [No Abstract]   [Full Text] [Related]  

  • 12. Sertraline-induced enuresis in a prepubertal child resolves after switching to fluoxetine.
    Maalouf FT; Gilbert AR
    J Child Adolesc Psychopharmacol; 2010 Apr; 20(2):161-2. PubMed ID: 20415614
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of Fluoxetine on Obsessive-Compulsive Behaviors in Children and Adolescents With Autism Spectrum Disorders: A Randomized Clinical Trial.
    Reddihough DS; Marraffa C; Mouti A; O'Sullivan M; Lee KJ; Orsini F; Hazell P; Granich J; Whitehouse AJO; Wray J; Dossetor D; Santosh P; Silove N; Kohn M
    JAMA; 2019 Oct; 322(16):1561-1569. PubMed ID: 31638682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial.
    Geller DA; Hoog SL; Heiligenstein JH; Ricardi RK; Tamura R; Kluszynski S; Jacobson JG;
    J Am Acad Child Adolesc Psychiatry; 2001 Jul; 40(7):773-9. PubMed ID: 11437015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amotivational syndrome associated with selective serotonin reuptake inhibitors in children and adolescents.
    Garland EJ; Baerg EA
    J Child Adolesc Psychopharmacol; 2001; 11(2):181-6. PubMed ID: 11436958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoxetine in children and adolescents with OCD: a placebo-controlled trial.
    Liebowitz MR; Turner SM; Piacentini J; Beidel DC; Clarvit SR; Davies SO; Graae F; Jaffer M; Lin SH; Sallee FR; Schmidt AB; Simpson HB
    J Am Acad Child Adolesc Psychiatry; 2002 Dec; 41(12):1431-8. PubMed ID: 12447029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoxetine-induced extrapyramidal symptoms in an adolescent: a case report.
    Diler RS; Yolga AY; Avci A
    Swiss Med Wkly; 2002 Mar; 132(9-10):125-6. PubMed ID: 12046001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of fluoxetine on various subtypes of obsessive-compulsive disorder.
    Farnam A; Goreishizadeh MA; Farhang S
    Arch Iran Med; 2008 Sep; 11(5):522-5. PubMed ID: 18759519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind comparison of fluoxetine versus clomipramine in the treatment of obsessive compulsive disorder.
    López-Ibor JJ; Saiz J; Cottraux J; Note I; Viñas R; Bourgeois M; Hernández M; Gómez-Pérez JC
    Eur Neuropsychopharmacol; 1996 May; 6(2):111-8. PubMed ID: 8791036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluvoxamine: new indication. No progress in obsessive-compulsive disorder.
    Prescrire Int; 2004 Oct; 13(73):163-5. PubMed ID: 15499694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.